Literature DB >> 15325795

Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.

Jesús K Yamamoto-Furusho1, Luis F Uscanga, Gilberto Vargas-Alarcón, José M Rodríguez-Pérez, Joaquin Zuñiga, Julio Granados.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) gene is located within the class III region of the major histocompatibility complex (MHC) on the short arm of the human sixth chromosome. Two polymorphisms in the promoter region of the TNF-alpha gene (-308 and -238) have been associated with the genetic susceptibility to develop ulcerative colitis in both Caucasian and Asian populations. The aim of this study was to determine the role of TNF-alpha gene polymorphisms and those from the HLA-DRB1 locus in the susceptibility to develop ulcerative colitis (UC). Eighty Mexican mestizo patients suffering from UC and 99 ethnically matched unrelated healthy controls were genotyped for two TNF-alpha polymorphisms located in the promoter region (positions -308, -238) by polymerase chain reaction (PCR) and amplification refractory mutation system (ARMS) as well as high resolution DNA typing for HLA-DRB1 alleles were performed. The frequency of individuals positive for allele 2 of the TNF(-308) polymorphism was significantly higher in UC patients than healthy controls (23.7% versus 3%, pC = 0.00002; OR = 10.1; CI 95% = 2.69-26.8). No statistically significant deviation from normality was found between TNF*A (-238) and UC Mexican patients. Clinical manifestations such as pancolitis, extraintestinal manifestations and colectomy were not associated with any of the TNF promoter region polymorphisms. However, HLA-DRB1*15 was found to be associated with pancolitis and HLA-DRB1*0103 with the need of proctocolectomy. In conclusion, this clinical differential pattern of association distinguished in two neighboring loci within the MHC region suggest an independent role of the TNF locus in the genetic susceptibility to develop UC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325795     DOI: 10.1016/j.imlet.2004.05.015

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  13 in total

1.  ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease.

Authors:  Jaime Sánchez-Cuén; Maribel Aguilar-Medina; Eliakym Arámbula-Meraz; José Romero-Navarro; Julio Granados; Laura Sicairos-Medina; Rosalío Ramos-Payán
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  Genetic factors associated with the development of inflammatory bowel disease.

Authors:  Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

3.  Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk.

Authors:  Lynnette R Ferguson; Claudia Huebner; Ivonne Petermann; Richard B Gearry; Murray L Barclay; Pieter Demmers; Alan McCulloch; Dug Yeo Han
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 4.  The use of prognostic factors in inflammatory bowel diseases.

Authors:  Thomas Billiet; Marc Ferrante; Gert Van Assche
Journal:  Curr Gastroenterol Rep       Date:  2014-11

5.  Assessment of biochemical parameters and characterization of TNFα -308G/A and PTPN22 +1858C/T gene polymorphisms in the risk of obesity in adolescents.

Authors:  Mauricio Andrés Salinas-Santander; Rafael Baltazar León-Cachón; Ana Cecilia Cepeda-Nieto; Celia Nohemí Sánchez-Domínguez; María Antonia González-Zavala; Hugo Leonid Gallardo-Blanco; Sandra Cecilia Esparza-González; Miguel Ángel González-Madrazo
Journal:  Biomed Rep       Date:  2015-10-27

6.  Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.

Authors:  Jesus K Yamamoto-Furusho; Luis Uscanga-Domínguez; Alondra Lopez-Martinez; Julio Granados
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 7.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

8.  Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis.

Authors:  Wang Fan; Wang Maoqing; Chen Wangyang; Hu Fulan; Li Dandan; Ren Jiaojiao; Dong Xinshu; Cui Binbin; Zhao Yashuang
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

9.  Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population.

Authors:  Mauricio Salinas-Santander; Daniel Díaz-García; Augusto Rojas-Martínez; Cristina Cantú-Salinas; Celia Sánchez-Domínguez; Miguel Reyes-López; Ricardo M Cerda-Flores; Jorge Ocampo-Candiani; Rocío Ortiz-López
Journal:  Exp Ther Med       Date:  2012-03-09       Impact factor: 2.447

Review 10.  Novel genetic markers in inflammatory bowel disease.

Authors:  Lorena Rodriguez-Bores; Gabriela-C Fonseca; Marco-A Villeda; Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.